We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Oxytocin Buffers Stress Response in Individuals With Impaired Coping Abilities

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01065610
Recruitment Status : Completed
First Posted : February 9, 2010
Last Update Posted : February 9, 2010
Sponsor:
Information provided by:

Study Description
Brief Summary:
This study investigated, if people with impaired coping abilities benefit from intranasal oxytocin application.

Condition or disease Intervention/treatment
Coping Skills Oxytocin Stress Drug: Oxytocin Drug: Placebo

Study Design

Study Type : Interventional  (Clinical Trial)
Official Title: Oxytocin Buffers Cortisol Responses to Stress in Individuals With Impaired Coping Abilities
Study Start Date : January 2008
Primary Completion Date : October 2008
Study Completion Date : October 2008

Resource links provided by the National Library of Medicine

Drug Information available for: Oxytocin
U.S. FDA Resources

Arms and Interventions

Arm Intervention/treatment
Experimental: Oxytocin
Intranasal Oxytocin, 24 IU
Drug: Oxytocin
Placebo Comparator: Placebo Drug: Placebo


Outcome Measures

Primary Outcome Measures :
  1. Salivary Cortisol

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 50 Years   (Adult)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • male

Exclusion Criteria:

  • psychological disorders
  • drug abuse
  • cigarette smoking
  • coronary diseases
  • nervous system diseases
More Information

ClinicalTrials.gov Identifier: NCT01065610     History of Changes
Other Study ID Numbers: Neurolab_RD_001
First Posted: February 9, 2010    Key Record Dates
Last Update Posted: February 9, 2010
Last Verified: January 2010

Additional relevant MeSH terms:
Oxytocin
Oxytocics
Reproductive Control Agents
Physiological Effects of Drugs